Cough Effectiveness and Pulmonary Hygiene Practices in Patients with Pompe Disease.
Adolescent
Adult
Age of Onset
Aged
Child
Child, Preschool
Cough
/ physiopathology
Female
Glycogen Storage Disease Type II
/ diagnosis
Humans
Infant
Lung
/ physiopathology
Male
Middle Aged
Mucociliary Clearance
Prospective Studies
Respiration
Respiration, Artificial
Respiratory Muscles
/ physiopathology
Respiratory Therapy
/ methods
Treatment Outcome
Young Adult
Cough
Pompe disease
Pulmonary hygiene
Respiratory muscles
Journal
Lung
ISSN: 1432-1750
Titre abrégé: Lung
Pays: United States
ID NLM: 7701875
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
28
06
2018
accepted:
12
10
2018
pubmed:
27
10
2018
medline:
16
1
2020
entrez:
27
10
2018
Statut:
ppublish
Résumé
While factors leading to hypoventilation have been well studied in Pompe disease, cough effectiveness and airway clearance practices are less understood. We aimed to identify significant factors that influence peak cough flow (PCF) in Pompe, and to detect whether pulmonary hygiene practices were reflective of reduced PCF. This is a prospective observational study of 20 subjects with Pompe disease (infantile-onset: 7, juvenile-onset: 6, adult-onset: 14). Subjects performed spirometry, maximal respiratory pressures, and cough (voluntary: n = 24, spontaneous: n = 3). Subjects or their parents reported airway clearance and secretion management practices. Relationships between disease variables, pulmonary function, and cough parameters as well as group differences in cough parameters were evaluated. Subjects with infantile-onset disease had significantly lower PCF (p < 0.05) and tended to require more external ventilatory support (p = 0.07). In juvenile- and adult-onset disease, PCF differed according to external ventilatory requirement [daytime: 83.6 L/min (95% CI 41.2-126.0); nighttime: 224.6 L/min (95% CI 139.1-310.2); none: 340.2 L/min (95% CI 193.3-487.6), p < 0.005]. Cough inspiratory volume also differed significantly by ventilatory requirement [daytime: 5.5 mL/kg (95% CI 3.0-8.0); nighttime: 16.0 mL/kg (95% CI 11.8-20.2); none: 26.8 mL/kg (95% CI 11.9-41.7), p < 0.001]. However, routine airway clearance or secretion management practices were only consistently reported among patients with infantile-onset disease (infantile: 86%, juvenile: 0%, adult: 14%, p < 0.005). Cough weakness was detected in the majority of patients with Pompe disease and was influenced by both inspiratory and expiratory muscle function. Patients at risk for problems or with ineffective PCF should be urged to complete routine pulmonary hygiene.
Identifiants
pubmed: 30361764
doi: 10.1007/s00408-018-0171-1
pii: 10.1007/s00408-018-0171-1
pmc: PMC6366453
mid: NIHMS1510590
doi:
Types de publication
Comparative Study
Journal Article
Observational Study
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-8Subventions
Organisme : NICHD NIH HHS
ID : R21 HD090752
Pays : United States
Références
Respir Physiol Neurobiol. 2016 Feb 1;222:11-5
pubmed: 26612101
Ther Clin Risk Manag. 2015 Sep 28;11:1475-88
pubmed: 26451113
Chest. 2015 Nov;148(5):1259-1267
pubmed: 26134718
Am J Phys Med Rehabil. 2008 Jun;87(6):461-7
pubmed: 18496248
Chest. 1996 Dec;110(6):1566-71
pubmed: 8989078
Eur Respir J. 2012 Jun;39(6):1545-6
pubmed: 22654013
Int J Mol Sci. 2016 Oct 17;17(10):
pubmed: 27763517
Thorax. 2012 Jul;67 Suppl 1:i1-40
pubmed: 22730428
Neuromuscul Disord. 2006 May;16(5):325-8
pubmed: 16621559
Respir Care. 2017 Apr;62(4):432-443
pubmed: 28196935
Mol Genet Metab. 2016 Feb;117(2):120-8
pubmed: 26381077
Muscle Nerve. 2009 Jul;40(1):149-60
pubmed: 19533647
J Appl Physiol Respir Environ Exerc Physiol. 1981 Aug;51(2):494-8
pubmed: 7263456
Cochrane Database Syst Rev. 2013 Dec 30;(12):CD010044
pubmed: 24374746
Respir Physiol Neurobiol. 2017 Jun;240:17-25
pubmed: 28213202
Mol Genet Metab. 2013 Nov;110(3):290-6
pubmed: 23916420
Orphanet J Rare Dis. 2017 Mar 16;12(1):52
pubmed: 28302142
Respir Physiol Neurobiol. 2013 Nov 1;189(2):241-9
pubmed: 23797185
Chest. 2006 Jan;129(1 Suppl):48S-53S
pubmed: 16428691
Am J Med Genet C Semin Med Genet. 2012 Feb 15;160C(1):59-68
pubmed: 22253258
Respir Physiol Neurobiol. 2005 Apr 15;146(2-3):291-300
pubmed: 15766917
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
Orphanet J Rare Dis. 2015 May 06;10:54
pubmed: 25943355
Chest. 1997 Oct;112(4):1024-8
pubmed: 9377912
Am J Respir Crit Care Med. 2002 Aug 15;166(4):518-624
pubmed: 12186831
Am J Phys Med Rehabil. 2012 Aug;91(8):666-70
pubmed: 22561386
BMC Pulm Med. 2015 May 06;15:54
pubmed: 25943437
Respir Med. 2018 Mar;136:98-110
pubmed: 29501255
Orphanet J Rare Dis. 2011 Jun 01;6:34
pubmed: 21631931
Chest. 2010 May;137(5):1033-9
pubmed: 20040608
Eur Respir J. 2003 Mar;21(3):502-8
pubmed: 12662009